• Архив журнала /
• 2015 /
• №4

Тромболизис в исследовании Pediatric Stroke Study

М.Дж. Ривкин, Г. деВебер, Р.Н. Икхорд, К. Киртон, А.К. Чан, К.А. Ховинга, Дж.К. Гилл, А. Сзабо, М.Д. Хилл, К. Шольц, К. Амли-Лефонд

Departments of Neurology, Psychiatry and Radiology, Boston Children’s Hospital, and Department of Neurology, Harvard Medical School, Boston, MA; Division of Neurology, Department of Pediatrics, Hospital for Sick Children Toronto, Ontario, Canada; The Children’s Hospital ­ of Philadelphia, Departments of Neurology and Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia; Department of Neurology, Alberta Children‘s Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada Alberta Children’s Hospital and Department of Clinical Neurosciences and Hotchkiss Brain Institute, University of Calgary, Alberta, Canada; Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada; Dell Children‘s Medical Center and University of Texas at Austin College of Pharmacy; BloodCenter of Wisconsin and Department of Pediatrics and Division of Biostatistics, Medical College of Wisconsin, Milwaukee; Center for Integrated Brain Research, Seattle Children’s Research Institute, WA; and Seattle Children‘s Hospital, Department of Neurology, University of Washington, Seattl.

Литература

1. Fullerton H.J., Wu Y.W., Zhao S., Johnston S.C. Risk of stroke in children: ethnic and gender disparities. Neurology. 2003;61:189–194.
2. Lynch J.K., Hirtz D.G., DeVeber G., Nelson K.B. Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics. 2002;109:116–123.
3. Schoenberg B.S., Mellinger J.F., Schoenberg D.G. Moyamoya disease in children. South Med J. 1978;71:237–241.
4. De Schryver E.L., Kappelle L.J., Jennekens-Schinkel A., Boudewyn Peters A.C. Prognosis of ischemic stroke in childhood: a long-term follow-up study. Dev Med Child Neurol. 2000;42:313–318.
5. deVeber G.A., MacGregor D., Curtis R., Mayank S. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J Child Neurol. 2000;15:316–324.
6. Fullerton H.J., Chetkovich D.M., Wu Y.W., Smith W.S., Johnston S.C. Deaths from stroke in US children, 1979 to 1998. Neurology. 2002;59:34–39.
7. Ganesan V., Hogan A., Shack N., Gordon A., Isaacs E., Kirkham F.J. Outcome after ischaemic stroke in childhood. Dev Med Child Neurol. 2000;42:455–461.
8. Lo W., Zamel K., Ponnappa K., Allen A., Chisolm D., Tang M., et al. The cost of pediatric stroke care and rehabilitation. Stroke. 2008;39:161–165. doi: 10.1161/STROKEAHA.107.497420.
9. Jauch E.C., Saver J.L., Adams H.P. Jr, Bruno A., Connors J.J., Demaerschalk B.M., et al; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870–947. doi: 10.1161/STR.0b013e318284056a.
10. Parmar N., Albisetti M., Berry L.R., Chan A.K. The fibrinolytic system in newborns and children. Clin Lab. 2006;52:115–124.
11. Amlie-Lefond C., deVeber G., Chan A.K., Benedict S., Bernard T., Carpenter J., et al; International Pediatric Stroke Study. Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study. Lancet Neurol. 2009;8:530–536. doi: 10.1016/S1474-4422(09)70106-1.
12. Janjua N., Nasar A., Lynch J.K., Qureshi A.I. Thrombolysis for ischemic stroke in children: data from the nationwide inpatient sample. Stroke. 2007;38:1850–1854. doi: 10.1161/STROKEAHA.106.473983.
13. Monagle P., Chan A.K., Goldenberg N.A., Ichord R.N., Journeycake J.M., Nowak-Göttl U., et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):e737S–801S.
14. Roach E.S., Golomb M.R., Adams R., Biller J., Daniels S., Deveber G., et al; American Heart Association Stroke Council; Council on Cardiovascular Disease in the Young. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke. 2008;39:2644–2691. doi: 10.1161/STROKEAHA.108.189696.
15. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7.
16. Putaala J., Metso T.M., Metso A.J., Mäkelä E., Haapaniemi E., Salonen O., et al. Thrombolysis in young adults with ischemic stroke. Stroke. 2009;40:2085–2091. doi: 10.1161/STROKEAHA.108.541185.
17. Dzialowski I., Pexman J.H., Barber P.A., Demchuk A.M., Buchan A.M., Hill M.D.; CASES Investigators. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry. Stroke. 2007;38:75–79. doi: 10.1161/01.STR.0000251644.76546.62.
18. Andrew M., Vegh P., Johnston M., Bowker J., Ofosu F., Mitchell L. Maturation of the hemostatic system during childhood. Blood. 1992;80:1998–2005.
19. Monagle P., Barnes C., Ignjatovic V., Furmedge J., Newall F., Chan A., et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost. 2006;95:362–372. doi: 10.1267/THRO06020362.
20. Siegbahn A., Ruusuvaara L. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Thromb Haemost. 1988;60:361–364.
21. Monagle P., Chan A.K., Albisetti M., Vegh P., Andrew M., Mitchell L. Fibrinolytic system in adolescents: response to venous occlusion stress tests. Pediatr Res. 2003;53:333–337. doi: 10.1203/01. PDR.0000047644.97422.F2.
22. Evans W.E., Relling M.V., de Graaf S., Rodman J.H., Pieper J.A., Christensen M.L., et al. Hepatic drug clearance in children: studies with indocyanine green as a model substrate. J Pharm Sci. 1989;78:452–456.
23. Strolin B.B.E. Drug metabolism and disposition in children. Fundam Clin Pharmacol. 2003;17:281–299.
24. Murry D.J., Crom W.R., Reddick W.E., Bhargava R., Evans W.E. Liver volume as a determinant of drug clearance in children and adolescents. Drug Metab Dispos. 1995;23:1110–1116.
25. McGlennan C., Ganesan V. Delays in investigation and management of acute arterial ischaemic stroke in children. Dev Med Child Neurol. 2008;50:537–540. doi: 10.1111/j.1469-8749.2008.03012.x.
26. Rafay M.F., Pontigon A.M., Chiang J., Adams M., Jarvis D.A., Silver F., et al. Delay to diagnosis in acute pediatric arterial ischemic stroke. Stroke. 2009;40:58–64. doi: 10.1161/STROKEAHA.108.519066.
27. Gabis L.V., Yangala R., Lenn N.J. Time lag to diagnosis of stroke in children. Pediatrics. 2002;110:924–928.
28. Braun K.P., Kappelle L.J., Kirkham F.J., Deveber G. Diagnostic pitfalls in paediatric ischaemic stroke. Dev Med Child Neurol. 2006;48:985–990. doi: 10.1017/S0012162206002167.
29. Srinivasan J., Miller S.P., Phan T.G., Mackay M.T. Delayed recognition of initial stroke in children: need for increased awareness. Pediatrics. 2009;124:e227–e234. doi: 10.1542/peds.2008-3544.
30. Bernard T.J., Rivkin M.J., Scholz K., deVeber G., Kirton A., Gill J.C., et al; Thrombolysis in Pediatric Stroke Study. Emergence of the primary pediatric stroke center: impact of the thrombolysis in pediatric stroke trial. Stroke. 2014;45:2018–2023. doi: 10.1161/STROKEAHA.114.004919.
31. Ji Y., Li Y., Nebiyou Bekele B. Dose-finding in phase I clinical trials based on toxicity probability intervals. Clin Trials. 2007;4:235–244. doi:10.1177/1740774507079442.
32. Ichord R.N., Bastian R., Abraham L., Askalan R., Benedict S., Bernard T.J., et al. Interrater reliability of the Pediatric National Institutes of Health Stroke Scale (PedNIHSS) in a multicenter study. Stroke. 2011;42:613–617. doi: 10.1161/STROKEAHA.110.607192.
33. Lo W., Gordon A.L., Hajek C., Gomes A., Greenham M., Anderson V., et al. Pediatric stroke outcome measure: predictor of multiple impairments in childhood stroke. J Child Neurol. 2014;29:1524–1530. doi:10.1177/0883073813503186.
34. Kitchen L., Westmacott R., Friefeld S., MacGregor D., Curtis R., Allen A., et al. The pediatric stroke outcome measure: a validation and reliability study. Stroke. 2012;43:1602–1608. doi: 10.1161/STROKEAHA.111.639583.
35. Calvert S., Miller H.E., Curran A., Hameed B., McCarter R., Edwards R.J., et al. The King’s Outcome Scale for Childhood Head Injury and injury severity and outcome measures in children with traumatic brain injury. Dev Med Child Neurol. 2008;50:426–431. doi:10.1111/j.1469-8749.2008.02061.x.
36. Feldman A.B., Haley S.M., Coryell J. Concurrent and construct validity of the Pediatric Evaluation of Disability Inventory. Phys Ther.1990;70:602–610.
37. Berger C., Fiorelli M., Steiner T., Schäbitz W.R., Bozzao L., Bluhmki E., et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke. 2001;32:1330–1335.
38. Hacke W., Kaste M., Fieschi C., Toni D., Lesaffre E., von Kummer R., et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017–1025.
39. Toni D., Lorenzano S., Puca E., Prencipe M. The SITS-MOST registry. Neurol Sci. 2006;27(suppl 3):S260–S262. doi: 10.1007/s10072-006-0632-9.

Похожие статьи

• Применение электромеханических устройств для тренировки ходьбы после инсульта. Обновленные данные
• Моделирование иммунитета и воспаления при инсульте. Можно ли доверять мышам?
• Методы эндоваскулярного лечения острого ишемического инсульта: от внутриартериального введения фибринолитиков до стент-ретриверных систем
• Морфология ‟susceptibility vessel sign” является предиктором реканализации средней мозговой артерии после тромболизиса
• Гранулоцитарный колониестимулирующий фактор у пациентов с острым ишемическим инсультом. Результаты испытания AX200 for Ischemic Stroke